MC-Val-Cit-PAB-Auristatin E is a cleavable linker-payload for constructing antibody-drug conjugates (ADCs). Its auristatin E warhead potently inhibits tubulin polymerization. This compound is widely used in oncology research for developing targeted therapies and has demonstrated antitumor efficacy in both in vitro and in vivo models.